chartexchange

THOR
Thornburg Premium Income Builder ETF
stockNYSEETF

At CloseNov 13, 2026 3:59:28 PM EST
26.18USD-0.076%(-0.02)22,868
After-hoursNov 16, 2026 4:10:30 PM EST
25.87USD-1.170%(-0.31)
Loading…
Loading…
830.01M
Sector
Healthcare
Industry
Health Services
Previous Close
$25.87
Beta
0.43
52-Week High
$28.99 2026-08-18
52-Week Low
$24.52 2026-07-01
SMA 50
$25.68
SMA 200
$28.99
Avg. Vol 10D
89,543
Avg. Vol 30D
61,608
Avg. Vol 90D
36,655
Relative Vol
0.37
32.34M
135.8600%
101,913
Nov 5, 2026
Oct 29, 2026
Oct 14, 2026
Sep 22, 2026
THOR Profile

Thoratec Corporation, together with its subsidiaries, develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company’s primary product lines include ventricular assist devices, including HeartMate II, an implantable, electrically powered, continuous flow, left ventricular assist device (LVAD) consisting of a rotary blood pump designed to provide intermediate and long-term mechanical circulatory support (MCS); CentriMag an extracorporeal circulatory support device that provides hemodynamic stabilization in patients in need of cardiopulmonary support. It also offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms incorporating a polycarbonate pump, based on magnetically levitated bearingless motor technology, designed to provide acute surgical support to pediatric patients. In addition, it provides Thoratec Paracorporeal Ventricular Assist Device (PVAD) an external, pulsatile ventricular assist device (VAD), FDA-approved for bridge-to-transplantation (BTT) and post-cardiotomy myocardial recovery; and Thoratec Implantable Ventricular Assist Device (IVAD) an implantable, pulsatile, VAD, FDA-approved for BTT, including home discharge, and post-cardiotomy myocardial recovery and provides left, right or biventricular MCS The company markets its products through cardiovascular sales specialists and distributors in the United States and internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

THOR Performance
PeriodPriceDateChangeBeta
1W26.112026-11-10-1.72%0.462
1M25.492026-10-16+0.69%0.528
3M26.292026-08-17-2.38%0.468
6M24.982026-06-23+2.74%0.430
5Y67.992020-01-22-62.25%1.551
THOR Stock Summary

Thornburg Premium Income Builder ETF (NYSE:THOR) stock price today is $25.67, and today's volume is 22,867. THOR is down 0.807% today. The 30 day average volume is 61,608. THOR market cap is $830.01M with 32.34M shares outstanding.